戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 Between February 2001 and February 2002, 946 patients were accrued.
2        From April 2001 to February 2008, 345 patients were accrued.
3                   One hundred and forty-four patients were accrued.
4                      A total of 745 eligible patients were accrued.
5                                 Thirty-eight patients were accrued.
6       Between December 2001 and May 2005, 55 patients were accrued.
7 ted prematurely after 224 of a projected 400 patients were accrued.
8 tween April 1, 1995, and June 1, 1999, 1,323 patients were accrued.
9        Between July 1998 and August 2003, 36 patients were accrued; 31 were eligible.
10                                   Forty-five patients were accrued; 44 patients received treatment.
11                                   Forty-four patients were accrued; 60% had stage III to IV disease;
12                                  Thirty-five patients were accrued, all of whom had failed one (51%)
13                        Fifty-eight evaluable patients were accrued and randomly assigned from 2004 to
14                               A total of 368 patients were accrued and received therapy.
15                  Three hundred seventy-three patients were accrued at more than 60 centers; 251 patie
16 n as the recommended dose, and 12 additional patients were accrued at that level.
17                               Ten additional patients were accrued at the 1.3 mg/m2 bortezomib dose l
18                                  Sixty-seven patients were accrued between March 1994 and April 1996.
19                               A total of 380 patients were accrued between May 1990 and June 1994 int
20                               Two additional patients were accrued beyond the protocol-stipulated 46,
21                                   In all, 98 patients were accrued (cohort A, 12; cohort B, 86).
22                         Thirty-nine eligible patients were accrued (eight patients each on cohorts 1
23                       Six hundred ninty-nine patients were accrued for a SLNB with an average age 57.
24                               A total of 223 patients were accrued from 1996 to 1999.
25                                  In all, 251 patients were accrued from 1998 to 2002.
26 rophylaxis of pain flare after radiotherapy, patients were accrued from 23 Canadian centers from May
27        Between July 1998 and August 1999, 96 patients were accrued from 43 institutions.
28                                  In all, 107 patients were accrued: gemcitabine-docetaxel plus placeb
29                      Thirty-five consecutive patients were accrued in two institutions (22 in one and
30                               A total of 298 patients were accrued (median age, 68.8 [range, 32-94] y
31                                 Overall, 356 patients were accrued of the targeted 1,058.
32                                 Thirty-seven patients were accrued; one patient was ineligible.
33 before the standard use of temozolomide, 191 patients were accrued onto New Approaches to Brain Tumor
34                      Six hundred eighty-nine patients were accrued over 4.5 years; 89 patients (13%)
35                                              Patients were accrued primarily in the community setting
36                        Overall, 27 evaluable patients were accrued; the median number of prior therap
37                Fourteen nonimmunocompromised patients were accrued to a chemotherapy regimen that inc
38                           Forty-three and 26 patients were accrued to arms A and B, respectively.
39                                    Pediatric patients were accrued to clinical trials at high levels,
40                        Thirty-three eligible patients were accrued to dose levels 1 to 8.
41 red thirty-four, 234, 241, and 235 evaluable patients were accrued to groups 1, 2, 3, and 4, respecti
42                         Three hundred eleven patients were accrued to the Alabama Breast Cancer Proje
43        From March 2009 to December 2012, 153 patients were accrued to the study.
44               Forty-eight heavily pretreated patients were accrued to this study.
45             Thirty-five minimally pretreated patients were accrued using a standard two-step mechanis
46                   From 255 hospitals, 22,346 patients were accrued who underwent a colon resection in
47                        Ninety-seven eligible patients were accrued with a median follow-up time of 22
48                               Fifty eligible patients were accrued with tumor-node (TN) substage conf
49                                A total of 39 patients were accrued, with 36 patients being assessable

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。